Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

14 results
Display

A Case of Prolonged QT Interval Association with Galantamine

Park JC, Kim BS, Park SM, Park IW, Hong YM, Jeong JH, Cha TJ

  • KMID: 1993598
  • Kosin Med J.
  • 2011 Dec;26(2):179-182.
Among the Acetylcholinesterase inhibitors as used for Alzheimer's disease treatment, Galantamine has been recently developed and widely used owing to proven its clinical efficacy and safety. However, it has reported...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Study on the Association Between Cholineacetyltransferase(ChAT) Polymorphism and Treatment Responses of Galantamine in Alzheimer's Disease Patients

Lee YM, Seo MK, Kim DK

  • KMID: 1481938
  • J Korean Geriatr Psychiatry.
  • 2008 Jun;12(1):28-33.
Cholineacetyltrasnferase (ChAT) is a key enzyme that facilitates synthesis of acetylcholine affecting the memory, learning, awakening and sleep process of the cerebrum. The object of this study was to test...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Economic and Clinical Benefits of Galantamine in the Treatment of Mild to Moderate Alzheimer's Disease in a Korean Population: A 52-Week Prospective Study

Suh GH, Jung HY, Lee CU, Choi S, Korean Galantamine Study Group

To evaluate the impact of galantamine treatment on the function, caregiver time, and resource used in the treatment of patients with mild to moderate Alzheimer's disease (AD), costs and outcomes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Galantamine Treatment on Attention, Activities of Daily Living, and Neuropsychiatric Symptoms between the Patients with Pure Alzheimer's Disease and Mixed Dementia

Kang HS, Yun JH, Ahn IS, Moon YJ, Hwang TY, Lee YM, Kim H, Kim DK

  • KMID: 2334170
  • J Korean Geriatr Psychiatry.
  • 2012 Jun;16(1):24-30.
OBJECTIVES: The purpose of this study was to compare the efficacy of galantamine treatment, especially attention ability between patients with pure Alzheimer's disease (AD) and Mixed dementia (MD) during a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Galantamine Hydrobromide Treatment on Dehydroepiandrosterone Sulfate and Cortisol Levels in Patients with Chronic Fatigue Syndrome

Turan T, Izgi HB, Ozsoy S, Tanriverdi F, Basturk M, Asdemir A, Besirli A, Esel E, Sofuoglu S

  • KMID: 2315838
  • Psychiatry Investig.
  • 2009 Sep;6(3):204-210.
OBJECTIVE: Mental fatigue, cognitive disorders, and sleep disturbances seen in chronic fatigue syndrome (CFS) may be attributed to cholinergic deficit. A functional deficiency of cholinergic neurotransmission may cause the hypothalamic-pituitary-adrenal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Galantamine on Cognition in Mild-to-Moderate Alzheimer's Dementia after Failure to Respond to Donepezil

Hwang TY, Ahn IS, Kim S, Kim DK

OBJECTIVE: This study compares the efficacy of the cholinesterase inhibitor (ChEI) galantamine on cognition in patients with mild-to-moderate Alzheimer's dementia (AD) who were either naïve to ChEI drugs or who...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Galantamine on Caregiver Time and Activities of Daily Living in Mild to Moderate Alzheimer's Disease: A 1-Year Prospective Study

Suh GH, Jung HY, Lee CU, Lee SK, Lee NJ, Kim JH, Kee BS, Ko DG, Kim YH, Hong IJ, Choi S, Gold M, The Korean Galantamine Study Group

  • KMID: 1513932
  • J Korean Geriatr Soc.
  • 2007 Jun;11(2):74-82.
OBJECTIVE: This study aims to investigate the effect of galantamine on caregiver time and activities of daily living(ADLs) in patients with mild to moderate Alzheimer's disease(AD) in a Korean population. DESIGN:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effects of Galantamine Treatment on Attention and Its Relationship with Cognition and Activities of Daily Living in Patients with Mild to Moderate Alzheimer's Disease

Lee JH, Hong YJ, Bae HJ, Kim BJ, Na DL, Han SH, Park JM, Jeong JH, Cha KR

BACKGROUND AND PURPOSE: The positive effects of galantamine on cognition and activities of daily living (ADL) in Alzheimer's disease (AD) are thought to be mediated via improvements in attention. The...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Drug Therapy for Alzheimer's Disease

Suh GH

Alzheimer's disease (AD) is the most common cause of dementia in the elderly. AD afflicts 0.3 to 0.5 million people in Korea, and the number is projected to increase to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Single Treatment of Anti-Dementia Drugs on Sleep-Wake Patterns in Rats

Jung JY, Roh M, Ko KK, Jang HS, Lee SR, Ha JH, Jang IS, Lee HW, Lee MG

We studied the effects of acetylcholinesterase inhibitors, donepezil and galantamine, and an N-methyl-D-aspartate (NMDA) receptor blocker, memantine, on sleep-wake architecture in rats. Screw electrodes were chronically implanted into the frontal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
An Analysis on Prescribing Patterns of Alzheimer's Dementia Treatment and Choline Alfoscerate using HIRA Claims Data

Hwang SG, Park H

BACKGROUND: Alzheimer's dementia is the most common dementia. However, recently, choline alfoscerate is prescribed for treating Alzheimer's dementia, although it is not a treatment for this disease. PURPOSE: To analyze the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent Advances in Diagnosis and Treatment of Alzheimer's Disease

Lee JJ, Lee SB

Alzheimer's disease (AD) is a neurodegenerative disorder in which neuronal loss causes cognitive decline and other neuropsychiatric problems. It can be diagnosed based on history, examination, and appropriate objective assessments,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of Antioxidant, Anti-cholinesterase, and Anti-inflammatory Effects of Culinary Mushroom Pleurotus pulmonarius

Nguyen TK, Im KH, Choi J, Shin PG, Lee TS

Culinary mushroom Pleurotus pulmonarius has been popular in Asian countries. In this study, the anti-oxidant, cholinesterase, and inflammation inhibitory activities of methanol extract (ME) of fruiting bodies of P. pulmonarius...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Pseudocholinesterase and/or Neostigmine, Pyridostigmine, Edrophonium and Galanthamine for Reversal of Mivacurium- or Succinylcholine-induced Paralysis in Vitro

Cho SS, Yoon SN, Choi Y, Yang HS, Han SM, Kim SY, Suh BT

BACKGROUND: The hydrolysis of mivacurium and succinylcholine is impaired in the presence of defects of pseudocholinesterase. Clinical reports are conflicting as to the utility of anticholinesterases, in the reversal of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr